Investing in Merge Labs

OpenAI has confirmed an investment in Merge Labs, a company building brain-computer interfaces meant to link human cognition directly with machine intelligence. The stated goal, in OpenAI's own words, is to expand human ability, agency, and experience by closing the gap between biological and artificial systems.

That phrasing is vague on purpose. OpenAI hasn't detailed dollar amounts, timelines, or what a shipped Merge Labs product would actually look like. What we do know is the ambition: rather than just building smarter models that sit outside a person, OpenAI wants a stake in hardware that plugs into the person themselves.

This isn't happening in a vacuum. Neuralink, Elon Musk's implant company, has spent years testing devices in humans and racking up headlines for both progress and controversy. Sam Altman and Musk have a long, messy history, so an OpenAI-backed challenger in the BCI space reads as more than a coincidence. It's a bet that whoever controls the interface between brains and AI systems controls a huge amount of leverage over how future AI gets used.

Merge Labs is a small, relatively obscure name right now, which makes this investment more interesting than it might seem on the surface. OpenAI rarely writes checks for hardware plays outside its core software business. Putting capital into implantable or wearable neural tech signals the company sees the next competitive front not just in model capability, but in how directly that capability can be wired into a human body.